Market Overview
The Asia-Pacific Blood Glucose Monitoring Market is expected to register a CAGR of 8.83% during the forecast period of 2019–2024 and the market is estimated to reach USD 2 billion by 2019.
Asia-Pacific region has the highest diabetes population countries such as China and India with an average prevalence rate of more than 8%.
Blood glucose monitoring devices are used for effective diabetes diagnosis and treatment. A rise in the diabetic population drives the market by increasing the use of blood glucose monitoring devices.
Obesity is also considered as one of the major factor contributing to the disease condition mainly type 2 diabetes.
Also, other factors such as technological innovations and advances give much convenience in measuring the blood glucose levels, one such advancement in monitoring the blood glucose levels is established with Continuous glucose monitoring devices.
These devices help in early detection of hypo and hyperglycemic conditions which tend to drive the market for Glucose monitoring market.
Scope of the Report
Two main types of Blood Glucose monitoring devices included in this study. These devices further categorized into the Self-Monitoring Blood Glucose devices (SMBG) segmented into Glucometer devices, test strips, and lancets (which are also studied by their usage in Hospital and Home use individually) and Continuous Glucose Monitoring (CGM) devices segmented into sensors and receivers.
By Device type Self-Monitoring Blood Glucose devices By Component Glucometer Device
Blood Glucose Test Strips
Lancets
By End-User Hospital
Personal
Continuous Glucose Monitoring devices By Component Sensors
Receivers
By Region Asia Pacific Australia
China
India
Indonesia
Japan
Malaysia
Philippines
South Korea
Thailand
Vietnam
Rest of Asia Pacific
Key Market Trends
Self-blood glucose monitoring devices have high demand
Although CGM is an advanced way for people living with diabetes to check glucose readings in real-time, SMBG is the most preferred devices by the patients in the Asia-Pacific region due to its economic affordability and less sophisticated in usage when compared to CGM.
The SBGM occupies more than 93% of the market share in the Asia-Pacific blood glucose monitoring market. The further segmented market of SBGM gives an understanding that the disposable consumables – test strips and lancets occupies the highest market share than Glucometer devices.
China and India rank high in the diabetes population around the globe, and the market for diabetes is expected to increase at a high rate in these two countries during the forecast period.
CGM, though it provides real-time data of blood glucose levels for the patients, its adaptability is very low in Asia-Pacific markets. The cost factor is a major concern for the low growth of CGM in the Asia-Pacific market.
Asia-Pacific BGM market
China leading the Asia-Pacific market
China is facing the largest diabetes epidemic in the world with around 11% of its population suffering from metabolic illness, while nearly 36% are pre-diabetic.
In 2018, China held the largest share in the Asia-Pacific blood glucose monitoring market due to the large patient pool and wide acceptance of advanced technologies.
China BGM market
Competitive Landscape
The Asia-Pacific blood glucose monitoring market is highly fragmented with few major manufacturers having its presence in major countries of the Asia-Pacific market, while the remaining manufacturers confine to the other local or region-specific manufacturers.
Mergers and Acquisitions that happened between the players in the recent past helped the companies to strengthen their market presence. For example, Ascensia Diabetes Care, the Swiss tech company originally formed a few years ago from a merger of Bayer Health’s diabetes division and Panasonic Healthcare, is officially moving into the CGM space via a partnership with Huzhou, China-based Zhejiang POCTech.
Major Players
Roche
Abbott
Medtronics
Ascensia
Dexcom
1. INTRODUCTION
1. Study Deliverables
2. Study Assumptions
3. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. Market Overview
2. Drivers
3. Restraints
4. Porter's Five Forces Analysis
1. Bargaining Power of Suppliers
2. Bargaining Power of Consumers
3. Threat of New Entrants
4. Threat of Substitute Products and Services
5. Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. Self-Monitoring Blood Glucose devices
1. By Component (Market Size, Value and Volume)
1. Glucometer Devices
2. Test Strips
3. Lancets
2. By End User
1. Hospital (Market Size, Value and Volume)
1. Glucometer Devices
2. Test Strips
3. Lancets
2. Personal (Market Size, Value and Volume)
1. Glucometer Devices
2. Test Strips
3. Lancets
2. Continuous Blood Glucose Monitoring devices
1. By Component (Market Size, Value and Volume)
1. Sensors
2. Receivers
3. Geography
1. Asia-Pacific
1. Japan (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
2. South Korea (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
3. China (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
4. India (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
5. Australia (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
6. Vietnam (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
7. Malaysia (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
8. Indonesia (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
9. Philippines (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
10. Thailand (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
11. Rest of Asia Pacific (Market Size, Value and Volume)
1. Self-Monitoring Blood Glucose devices
1. By Component (Glucometer Device, Test strips, Lancets)
2. By End User (Hospital and Home)
3. By Company (Roche, Abbott, Johnson & Johnson and Others)
2. Continuous Glucose Monitoring
1. By Component (Sensors and Receivers)
2. By Company (Dexcom, Abbott, Medtronics and Others)
6. MARKET INDICATORS
1. Type-1 Diabetes population (2012-2024)
2. Type-2 Diabetes population (2012-2024)
7. COMPETITIVE LANDSCAPE
1. COMPANY PROFILES
1. Abbott Diabetes Care
2. Roche
3. Johnson & Johnson
4. Dexcom
5. Medtronic
6. Arkray
7. Ascensia Diabetes Care
8. Agamatrix Inc.
9. Bionime Corporation
10. Acon
11. Medisana
12. Trivida
13. Rossmax
2. COMPANY SHARE ANALYSIS
1. Roche
2. Johnson & Johnson
3. Abbott Diabetes Care
4. Dexcom
5. Medtronics
6. Others
8. MARKET OPPORTUNITES AND FUTURE TRENDS
+1 888 709 8757
Chat With Us